Skip to main content

Table 1 Modification of 5-HT receptor expression with human breast cancer status - Oncomine study

From: Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival

Study Type

Receptor Type

Variable

Direction of Change

P-value

(T-test)

Oncomine data source

Tumor grade/stage

HTR2B

Normal vs Breast Carcinoma

Higher in Cancer

0.002

Richardson et. al. [77]

  

Tumor stage N0-N3

Increase with stage

0.006

Bittner et. al. [78]

 

HTR2C

Tumor stage N0-N3

Increase with stage

0.009

Yu et. al. [79]

 

HTR7

Grade I to III

Increase with grade

<0.0001

Ivshina et. al. [80]

    

0.0001

Miller et. al. [81]

    

<0.01

Ginestier C et. al. [82]

More aggressive vs Less aggressive breast cancers

HTR1F

5 yrs recurrence- vs 5 yrs recurrence+

Higher in recurring tumors

0.005

VantVeer et. al. [83]

 

HTR2B

Lymph node- vs Lymph node+

Higher in lymph node +

0.006

Chin et. al. [84]

 

HTR2C

Primary vs Metastatic tumors

Higher in metastatic

0.001

Bittner et. al. [78]

  

Her2/neu- vs Her2/neu+

Higher in Her2/neu+

0.00057

Minn et. al. [85]

    

0.002

Hess KR et. al. [86]

 

HTR5A

P53-mutant vs p53-WT

Higher in p53-mutant

<0.0001

Miller et. al. [81]

 

HTR7

P53-mutant vs p53-WT

Higher in p53-mutant

0.008

Miller et. al. [81]

Steroid receptor status

HTR1F

ER+ vs ER-

Higher in ER+

0.0001

Sotiriou et. al. [87]

 

HTR2B

ER+ vs ER-

Higher in ER+

0.00014

Wang et. al. [88]

    

0.0004

Sotitiou et. al. [87]

    

0.00014

Desmedt et. al. [89]

  

Luminal vs Basal Tumors

Lower in Basal (ER-)

<0.0001

Farmer et. al. [90]

 

HTR4

ER+ vs ER-

Higher in ER+

0.001

Chi et. al. [84]

 

HTR7

ER+ vs ER-

Higher in ER+

<0.0001

VanderVijer et. al. [91]

    

0.00087

Bittner et. al. [78]

Human Mammary Cell lines

HTR2B

HMEC-Normal (GFP) vs c-Myc transformation

Higher in c-Myc transformed cells

0.001

Bild AH et. al. [92]

 

HTR7

HMEC-Normal (GFP) vs activated H-Ras

Higher in H-Ras cells

0.00028

Bild AH et. al. [92]

  1. Receptor mRNAs encoding 5-HT1F (HTR1F), 5-HT2B (HTR2B), 5-HT2C (HTR2C), 5-HT4 (HTR4), 5-HT5A (HTR5A) and 5-HT7 (HTR7) sorted as per tumor stage/grade, ER status, tumor aggressiveness and human mammary cell line transformation. Abbreviations: (ER+) - Estrogen Receptor Positive, (ER-) - Estrogen Receptor Negative. (HMEC) - human mammary epithelial cells.